Automotive manufacturers are making significant investments in the design and development of bioplastics and biocomposites-based components.

A recent advance in the evolutionary ladder of materials for orthopedic sports medicine applications involves composites made of one or more bioabsorbable polymers. This article describes preclinical and clinical results for a specific formulation comprising 30% beta tricalcium phoshate and 70% poly(lactide-coglycolide) polymer.